Literature DB >> 9158054

Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites.

F Al-Yaman1, B Genton, J C Reeder, R F Anders, M P Alpers.   

Abstract

Isolates of Plasmodium falciparum obtained from 12 children attending different health facilities in the Madang Province, Papua New Guinea were typed for allelic variants of merozoite surface protein-1 and merozoite surface protein-2. Blood was obtained just before treatment with either amodiaquine or chloroquine and at intervals following treatment. All patients examined were found to be infected with genetically different parasites. Nine of the children were found to have single infections while three had mixed infections. In all patients, parasites reappearing in the blood following treatment had the same genotype as parasites in the primary infection. These results indicate that parasites reappearing in the blood following treatment were the result of true recrudescence and not new infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9158054     DOI: 10.4269/ajtmh.1997.56.436

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.

Authors:  Agnès Aubouy; Mohamed Bakary; Annick Keundjian; Bernard Mbomat; Jean Ruffin Makita; Florence Migot-Nabias; Michel Cot; Jacques Le Bras; Philippe Deloron
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trial.

Authors:  Blaise Genton; Ivo Mueller; Inoni Betuela; Gerard Casey; Meza Ginny; Michael P Alpers; John C Reeder
Journal:  PLoS Clin Trials       Date:  2006-12-22

3.  Molecular incidence and clearance of Plasmodium falciparum infection.

Authors:  Donald J Krogstad; Ousmane A Koita; Mouctar Diallo; John L Gerone; Belco Poudiougou; Mahamadou Diakité; Yéya T Touré
Journal:  Malar J       Date:  2015-10-22       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.